Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 51 to 100 of 2387

TitleReference numberPublishedLast updated
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancerTA310
Aflibercept for treating choroidal neovascularisationTA486
Aflibercept for treating diabetic macular oedemaTA346
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusionTA409
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusionTA305
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapyTA307
Aflibercept solution for injection for treating wet age‑related macular degenerationTA294
Age-related macular degenerationNG82
Agomelatine for the treatment of major depressive episodes (terminated appraisal)TA231
AI technologies for detecting diabetic retinopathyMIB265
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan imagesDG55
Air pollution: outdoor air quality and healthNG70
Air pollution: outdoor air quality and healthQS181
Airglove air warming system for venous accessMIB151
Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesionsMIB15
Alair bronchial thermoplasty system for adults with severe difficult to control asthmaMIB71
Alcohol interventions in secondary and further educationNG135
Alcohol-use disorders: diagnosis and managementQS11
Alcohol-use disorders: diagnosis and management of physical complicationsCG100
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependenceCG115
Alcohol-use disorders: preventionPH24
Alcohol: preventing harmful use in the communityQS83
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal)TA438
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Alemtuzumab for treating highly active relapsing–remitting multiple sclerosisTA312
Alere Afinion CRP for C-reactive protein testing in primary careMIB81
AlignRT for intracranial stereotactic radiosurgeryMIB147
AlignRT in breast cancer radiotherapyMIB157
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemiaTA393
Alitretinoin for the treatment of severe chronic hand eczemaTA177
Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitusIPG257
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerTA816
Alpha-Stim AID for anxiety disordersMTG56
Alteplase for treating acute ischaemic strokeTA264
Amantadine, oseltamivir and zanamivir for the treatment of influenzaTA168
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopyMIB314
Ambu aScope 4 RhinoLaryngo for visualising upper airways during rhinolaryngoscopyMIB316
Ambu aScope4 Broncho for use in unexpected difficult airwaysMTG14
Ambulight PDT for the treatment of non-melanoma skin cancerMTG6
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyTA850
AmnioSense for unexplained vaginal wetness in pregnancyMIB198
Anakinra for treating Still's diseaseTA685
AnaphylaxisQS119
Anaphylaxis: assessment and referral after emergency treatmentCG134
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxabanTA697
Angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunctionIPG546
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)TA859
Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal)TA793
Antenatal and postnatal mental healthQS115

Results per page

  1. 10
  2. 25
  3. 50
  4. All